Adult Vaccines Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2024

Request Brochure Request Discount

Report Code: ZMR-3219 | Report Format : | Status : Upcoming |

Abstract

Global Adult Vaccines Market: Overview

A vaccine is a biological preparation that develops immunity to a specific disease. Immunization does not end in childhood. An adult’s immunity can wear off from childhood vaccinations, risking them for new and infectious diseases. Some vaccines may not be available in childhood; also the recommendations of vaccines may change over a period of years. Hence, it is important to be sure your adult immunizations are up-to-date especially if you are pregnant or planning to become pregnant. Immunizations needed by an adult are based on the factors such as health, age, lifestyle, medical conditions, travel and previous immunizations. All adults need certain immunizations which protect them against: Shingles  (adults 60 years and older), Pneumococcal (adults 65 years and older and adults with risk conditions), Seasonal influenza (flu) (all adults); tetanus, diphtheria, pertussis (whooping cough); Hepatitis B for adults who have diabetes or are at risk; chickenpox (varicella), and measles, mumps, and rubella.

Global Adult Vaccines Market: Growth Factors

Government is supporting to reduce the incidence of vaccine-preventable diseases, which indeed is driving the adult vaccine market vigorously. Growing awareness and efficiency of vaccines in preventing diseases will considerably grow in number for people opting for Zoster, Cervical Cancer (HPV), Hepatitis, Meningococcal vaccines in future till 2022. Innovative technology in the vaccine industry is driving the growth of the global adult vaccines market. However, the absence of technical professionals and huge capital demand are some of the major restraints for the global adult vaccines market. In addition, stringent governance and limited vaccines production are also impeding the growth of the global adult vaccines market. Complications and side effects associated with vaccinations also restrict the growth of the global adult vaccines market. Advancement in science would boost opportunities for global adult vaccines market.

Global Adult Vaccines Market: Segmentation

Global adult vaccines market is segmented by Vaccine Type (Monovalent and Multivalent); by indication (Hepatitis, Influenza, Tetanus/Diphtheria/Pertussis, Human Papilloma virus, Measles/mumps/Rubella, Pneumococcal, Meningococcal, Rotavirus, Varicella, and Others), by Technology (Inactivated Viral or Bacterial Vaccines, Live Attenuated Vaccines, Toxoid Vaccines, Conjugate Vaccines, Recombinant Vaccines, others), and by Region.

Global Adult Vaccines Market: Regional Analysis

In the global adult vaccines market, on a regional basis, the United States comprises the single biggest market being nearly followed by Europe. This is due to modernized research infrastructure in these regions.  Germany will advance at a considerable rate over the coming years due to increasing government initiatives to offer medical service for the vaccination.  Japan adult vaccines market share is anticipated to remain flat throughout the forecast period. South America and India are competing closely with each other to get the maximal share of the adult vaccines market due to increasing awareness among people about preventable diseases. Several government associations have started various programs to promote awareness among people towards diseases such as DTP, Influenza, measles, and mumps in Asia. 

Global Adult Vaccines Market: Competitive Players

Immunization currently prevents a predicted 2 to 3 million deaths every year.  Adult vaccines persist to be one of the growing segments for pharmaceutical companies. Some of the most important market players in the global adult vaccines market are Bharat Biotech, GlaxoSmithKline, Pfizer, Sanofi Pasteur, Merck and Co, Novartis, Serum Institute of India, Johnson & Johnson, CSL Limited, AstraZeneca Plc, Medimmune, Dynavax Technologies Corporation and ImmunoBiology Ltd.

Global Adult Vaccines Market: Regional Segment Analysis

  • North America
    • The U.S.
  • Europe
    • The UK
    • France
    • Germany
  • The Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • The Middle East and Africa

What Reports Provides

  • Full in-depth analysis of the parent market
  • Important changes in market dynamics
  • Segmentation details of the market
  • Former, on-going, and projected market analysis in terms of volume and value
  • Assessment of niche industry developments
  • Market share analysis
  • Key strategies of major players
  • Emerging segments and regional markets
  • Testimonials to companies in order to fortify their foothold in the market.

Related Reports

Real World Evidence Solutions Market by Component (Data Sets and Services), by Therapeutic Area (Oncology, Cardiovascular Disease, Neurology, Immunology, and Others), and by End-Users (Pharmaceutical and Medical Device Companies, Healthcare Payers, Healthcare Providers, and Others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 - 2026

Sep-2018 | Price : $ 4899.00 | Pages: 110 | Report Code: ZMR-3365 | Report Format:

The report covers forecast and analysis for the real world evidence solutions market on a global and regional level. The study provides historic data for 2016 and 2017 along with a forecast from 2018 to 2026 based on revenue (USD Million). The study includes drivers and restraints for the real wor...Read More

Oral Proteins and Peptides Market by Drug Type (Linaclotide, Plecanatide, Calcitonin, Insulin, and Octreotide) and by Application (Gastric & Digestive Disorders, Bone Diseases, Diabetes, Hormonal Disorders, and Others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2018 – 2024

Sep-2018 | Price : $ 4899.00 | Pages: 110 | Report Code: ZMR-3360 | Report Format:

The report covers forecast and analysis for the oral proteins and peptides market on a global and regional level. The study provides historical data from 2015 to 2017 along with a forecast from 2018 to 2024 based on revenue (USD Million). The study includes drivers and restraints for the oral prot...Read More

Medical Display Market by Technology (OLED, CCFL-Backlit LCD, and LED-Backlit LCD), by Display Color (Monochrome Displays and Color Displays), and by Resolution (Up to 2mp Resolution, 2.1–4mp Resolution, 4.1–8mp Resolution, and above 8mp Resolution), by Panel Size (Under-22.9-Inch, 23.0–26.9-Inch, 27.0–41.9-Inch, and Above-42-Inch), and by Application (Surgical, Diagnostic, Dentistry, and Others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 – 2024

Sep-2018 | Price : $ 4899.00 | Pages: 110 | Report Code: ZMR-3358 | Report Format:

The report covers forecast and analysis for the medical display market on a global and regional level. The study provides historic data for 2015, 2016, and 2017 along with a forecast from 2018 to 2024 based on revenue (USD Billion). The study includes drivers and restraints for the medical display...Read More

Facial Rejuvenation Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2024

Price : $ 3999.00 | Report Code: ZMR-3351 | Report Format:

Global Facial Rejuvenation Market: Overview Facial rejuvenation is a mixture of various medical and cosmetic procedures which are used in order to restore a youthful appearance to the human face. It can be achieved through non-invasive or minimally invasive surgical or non-surgical procedures. T...Read More

Scleroderma Diagnostics and Therapeutics Market by Drug Class (Immunosuppressive Agents, Corticosteroids, Endothelin Receptor Agonists, Calcium Channel Blockers, Chelating Agents, PDE-5 Inhibitors, H2 Blockers, Prostacyclin Analogues, ACE Inhibitors, and Proton Pump Inhibitors), by Indication (Systemic and Localized), and by Diagnostic Test Type (Imaging Techniques, Skin Biopsy, Electrocardiogram and Echocardiogram, Pulmonary Function Tests, and Blood Test): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 - 2024

Sep-2018 | Price : $ 4899.00 | Pages: 110 | Report Code: ZMR-3321 | Report Format:

The report covers forecast and analysis for the scleroderma diagnostics and therapeutics market on a global and regional level. The study provides historical data from 2015 along with a forecast from 2018 to 2024 based on revenue (USD Million). The study includes drivers and restraints for the scl...Read More

Download Brochure
Why Choose Us ?

24/5 Research support

Resolved your research queries from industry expert. Request for a free research sample before report purchase.

Custom research service

Ask the Analyst to customize an exclusive study to serve your research needs.

Quality & Accuracy

Zion Market Research reports offers best quality reports based on various authentic and accurate data findings.

Customer Satisfaction

We ensure that our client's all research needs are met with customized, in-depth analysis solutions.

Information security

We never share your personal and confidential information. Your personal information is safe and secure with us.